SignatureFD’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.7K | Buy |
1,392
+1,124
| +419% | +$12.7K | ﹤0.01% | 2154 |
|
|
2025
Q1 | $3.09K | Buy |
268
+187
| +231% | +$2.16K | ﹤0.01% | 2739 |
|
|
2024
Q4 | $686 | Sell |
81
-242
| -75% | -$2.05K | ﹤0.01% | 3089 |
|
|
2024
Q3 | $3.74K | Sell |
323
-27
| -8% | -$313 | ﹤0.01% | 2646 |
|
|
2024
Q2 | $4.12K | Buy |
350
+152
| +77% | +$1.79K | ﹤0.01% | 2571 |
|
|
2024
Q1 | $2.35K | Hold |
198
| – | – | ﹤0.01% | 2756 |
|
|
2023
Q4 | $2.43K | Buy |
198
+117
| +144% | +$1.43K | ﹤0.01% | 2707 |
|
|
2023
Q3 | $780 | Sell |
81
-7
| -8% | -$67 | ﹤0.01% | 2958 |
|
|
2023
Q2 | $792 | Buy |
+88
| New | +$792 | ﹤0.01% | 3008 |
|
|
2022
Q4 | – | Sell |
-548
| Closed | -$8K | – | 3342 |
|
|
2022
Q3 | $8K | Buy |
+548
| New | +$8K | ﹤0.01% | 2183 |
|